Searchable abstracts of presentations at key conferences in endocrinology

ea0056p818 | Pituitary - Clinical | ECE2018

Diabetes insipidus due to hypothalamitis and infundibulo-neurohypophysitis

Oruk G Gonca , Apaydin Melda

Autoimmune hypothalamitis has been implicated in idiopathic central diabetes insipidus (DI) due to antibodies against vasopressin producing hypothalamic cells. Lymphocytic infiltration of hypothalamus has been reported in patients with lymphocytic hypophysitis (LH) manifesting as hypopituitarism with DI. These patients can also have other associated autoimmune diseases. Here, we report a case of a male patient who presented with headache, poor orientation, partial hypopituitar...

ea0029p66 | Adrenal cortex | ICEECE2012

Comparison of salivary cortysol by chemiluminensce and mass spectometry in hypercortilosism

Marcelli G. , Concettoni C. , Scocco V. , Brugia M. , Tirabassi G. , Trementino L. , Boscaro M. , Arnaldi G.

BACKGROUND: The determination of Night Salivary Cortisol (NSC) is a useful survey in the screening for hypercortilosism. Study data about its usefulness, even when different methods of dosage are used, are anyway scarce.OBJECTIVE: To compare the diagnostic performance in the NSC dosage of the chemiluminescence method (CLIA) and of mass spectrometry (LC-MS/MS).METHODS: Saliva samples were taken at 11:00 pm in 36 healthy volunteers a...

ea0029p289 | Cardiovascular Endocrinology and Lipid Metabolism | ICEECE2012

Hypogonadism as a risk factor for cardiovascular mortality in men: a meta-analytic study

Rastrelli G. , Corona G. , Monami M. , Guay A. , Buvat J. , Sforza A. , Forti G. , Mannucci E. , Maggi M.

Objective: To verify whether hypogonadism represents a risk factor for cardiovascular (CV) morbidity and mortality and to verify whether testosterone replacement therapy (TRT) improves CV parameters in subjects with known CV diseases (CVDs).Design: Meta-analysis.Methods: An extensive Medline search was performed using the following words ‘testosterone, CVD, and males’. The search was restricted to data from January 1, 196...

ea0029p1024 | Male Reproduction | ICEECE2012

Inhibitors of 5α-reductase-related side effects in patients seeking medical care for sexual dysfunction

Rastrelli G. , Corona G. , Maseroli E. , Sforza A. , Forti G. , Mannucci E. , Maggi M.

Introduction: Despite their efficacy in the treatment of benign prostatic hyperplasia (BPH) the popularity of inhibitors of 5α-reductase (5ARIs) is limited by their association with adverse sexual side effects. However, the real impact of 5ARIs on sex hormones and sexual function is controversial.Aim: The aim of this study is to investigate the role of 5ARIs therapy on hormonal parameters and sexual function in men already complaining of sexual prob...

ea0029p1042 | Male Reproduction | ICEECE2012

Premature ejaculation and erectile dysfunction in a cohort of infertility men: clinical and ultrasonographic correlations

Lotti F. , Corona G. , Rastrelli G. , Forti G. , Jannini E. , Maggi M.

Introduction: Premature ejaculation (PE) and erectile dysfunction (ED) are considered pre-testicular causes of male subfertility. No previous study systematically evaluated the prevalence of ED and PE along with their possible correlations with clinical and colour-Doppler ultrasound (CDU) features in infertile men.Methods: Ejaculatory status, erectile function, prostatitis symptoms and psychopathological traits of 244 men complaining of couple infertilit...

ea0029p1559 | Steroid metabolism + action | ICEECE2012

Long-term evaluation of cross-sex hormone treatment in transsexual persons

Wierckx K. , Weyers S. , Caenegem E Van , Roef G. , Heylens G. , T'Sjoen G.

Objective: To describe the effects and side effects of cross-sex hormone therapy in both transsexual men and women.Design: Single center cross-sectional study in one hundred transsexual persons post SRS and on average 10 years on cross-sex hormone therapy.Methods: Hormone levels were measured by immunoassays. Physical health was assessed by physical examination and questionnaires on general health and specific side effects, areal b...

ea0026p166 | Neuroendocrinology | ECE2011

Evaluation of insulin secretion and sensitivity and lipid profile in GH deficient children before and at the end of rhGH therapy

Prodam F , Savastio S , Bellone S , Balossini C , Ricotti R , Genoni G , Aimaretti G , Bona G

Introduction: A rise in serum insulin levels during GH therapy is reported. Insulin resistance is a risk factor for type 2 diabetes, atherosclerosis, dyslipidemia, and hypertension. Few data describe insulin secretion and lipids after the end of GH therapy.Subjects and methods: Aim of our study was to evaluate changes in insulin secretion, sensitivity and lipid profile in children with isolated GHD longitudinally followed during rhGH treatment. We measur...

ea0026p510 | Bone/calcium/Vitamin D | ECE2011

Calcium homeostasis in diabetic postmenopausal women with bone fracture

Gusova A A , Pavlova M G , Melnichenko G A , Kavalersky G M , Silin L L , Zaitseva N V

Background and aims: The aim was to compare calcium homeostasis indexes in diabetic and non-diabetic patients with or without fractures.Materials and methods: We examined 62 postmenopausal women with type 2 diabetes mellitus (DM), 32 of them had bone fracture within last month. The control group included 54 non-diabetic women, 25 within a group were recently fractured. Groups were comparable in body mass index, age, duration of menopause and calcium inta...

ea0026p528 | Bone/calcium/Vitamin D | ECE2011

Diabetes mellitus and the incidence of fracture

Gusova A A , Pavlova M G , Melnichenko G A , Kavalersky G M , Silin L L , Zaitseva N V

Objective: To study if people with diabetes mellitus (DM) have increased risk of fracture.Methods: The study population consisted of 29 512 people aged 50 years or more. There were 1981 diabetic patients among them. The records of the local trauma clinic for two-year period were analyzed.Results: Women with DM had fewer fractures during two years than women without DM (relative risk 0.43; 95% confidence interval 0.30–0.61). Th...

ea0026p705 | Diabetes complications | ECE2011

Diabetes mellitus and risk of fracture

Gusova A A , Pavlova M G , Melnichenko G A , Kavalersky G M , Silin L L , Sountsov Yu I

Objective: To examine association between diabetes properties (type, duration, treatment regiment etc.) and risk of any fracture in diabetic population.Methods: We analyzed local trauma clinic data for 3 sequential years from 2662 diabetic persons who were entered The National Register of diabetes mellitus patients (133 subjects with type 1 diabetes mellitus (T1DM) and 1995 ones with T2DM).Results: Fracture risk was higher in T1DM ...